United States:
GAO Catalogues CMS Medicare Part D Program Integrity Practices
17 December 2014
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
A recent GAO report, "Medicare Program
Integrity: CMS Pursues Many Practices to Address Prescription Drug
Fraud, Waste, and Abuse," lists current and planned CMS
prevention, detection, and monitoring policies intended to promote
program integrity in the Medicare Part D prescription drug program.
The report does not include new recommendations.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Manatt Health: Health AI Policy Tracker
Manatt, Phelps & Phillips LLP
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI...